Home Latest Articles
Latest Articles
  • Tian-wei XIA, Le ShI, Yan-xin FAN, Chen YAO, Chao ZHANG, Ji-rong SHENG
    World Clinical Drug. 2018, 39(10): 677-682.
    Objective

    To investigate the efficacy of Shangke Xiaoyan Gao in the treatment of knee osteoarthritis (KOA).

    Methods

    Total of 78 patients suffered from KOA were randomly divided into two groups: Shangke Xiaoyan Gao group (treatment group, n=40) and diclofenac diethylamineemulgel group (control group, n=38). The treatment group was given Shangke Xiaoyan Gao, once a day, a sheet at a time;while the control group was given diclofenac diethylamineemulgel, three times a day, two grams at a time. The pain score, stiffness score, physical function score, WOMAC total score, traditional Chinese medicine (TCM) syndrome integral and auxiliary serum index before and after the two weeks of treatment were compared.

    Results

    Compared with before treatment, the knee pain score, daily activity score, WOMAC total score and TCM syndrome integral in treatment group were significantly improved (P<0.05), while the knee pain score in control group was significantly improved (P < 0.05). The comparison between the two groups showed that ESR had significant difference (P<0.05). The other indexes were not statistically significant (P>0.05). In improving WOMAC score, the effective rate in treatment group was 52.50%, while that in control group was 36.84%. There was no significant difference between the two groups (P>0.05). In improving TCM syndrome integral, the effective rate in treatment group (72.50%) was higher than that in control group (50.00%, P<0.05).

    Conclusion

    Shangke Xiaoyan Gao is effective for the treatment of KOA, and its clinical efficacy is superior to diclofenac diethylamineemulgel.

  • Mei-chun TAN, Lian-dong ZHANG, Xing-kai XU, Yun-xia LU
    World Clinical Drug. 2018, 39(10): 683-686.
    Objective

    To evaluate the urinary neutrophil gelatinase associated lipocalin (uNGAL) for the diagnosis of acute kidney injury (AKI) with sepsis.

    Methods

    Total of 38 cases of AKI patients with sepsis in the ICU within 7 days were selected as AKI group, and 63 cases without AKI criteria were selected as non-AKI group. The level of uNGAL was measured when the patients admitted in the ICU, at 0 h, 24 h, 48 h,72 h. The level of serum creatinine (Scr) was measured at 24 h in the ICU. The sensitivity and specificity of uNGAL for AKI diagnosis was evaluated by area under ROC (AUC).

    Results

    The uNGAL level in the AKI group was increased when the patient stayed in the ICU longer, and no obvious increase in the the non-AKI group. When admitted to the ICU 24 h, the level of uNGAL [(737.9±239.6) ng/ml] in AKI group was significantly higher than that in non-AKI group [(463.8±126.8) ng/ml, P<0.05]. The level of Scr between two groups was not statistically significant at 24 h in the ICU (P>0.05). At 24 h in the ICU, the AUC of uNGAL was 0.901 (95%CI: 0.816-0.931). When the cutoff value was 736.3 ng/ml, the sensitivity and specificity were 0.90 and 0.88 respectively.

    Conclusion

    uNGAL is superior to Scr for early diagnosis of the AKI patients with sepsis.

  • Jin-hui XIANG, Guo-qiang FU
    World Clinical Drug. 2018, 39(10): 687-690.
    Objective

    To investigate the effect of combined spinal and epidural anesthesia on the level of cortisol and D-dimer in cesarean section surgery.

    Methods

    A total of 64 patients undergoing cesarean section surgery in our hospital from December 2016 to January 2018 were randomly divided into the observation group and the control group by random number table as 32 cases in each group. The observation group received combined spinal and epidural anesthesia, and the control group received continuous epidural anesthesia. The indexes of coagulation function during operation and the levels of cortisol and D-dimer were monitored and compared between two groups.

    Results

    The significant difference in blood coagulation function (fibrinogen, prothrombin time, thrombin time) was not be found between the two groups (P>0.05). The cortisol levels in two groups were increased before operation, but there was no significant difference compared with that before anesthesia (P>0.05). However, it showed an upward trend after operation and a downward trend at 24 h and 72 h after operation, and the observation group was lower than control group (P<0.05). The change trend of D-dimer level was consistent with that of cortisol. It was slightly delayed for a period of time and gradually decreased at 72 h after operation. The level of D-dimer in observation group was lower than that in control group at 24 h and 72 h after operation (P<0.05).

    Conclusion

    For cesarean section surgery, the combined spinal and epidural anesthesia is more effective than continuous epidural anesthesia in inhibiting cortisol and D-dimer levels, which is more conducive to lower the stress level and improve the hypercoagulable state in cesarean section.

  • Hui-min PENG, Jian-mei CHEN, Shuai MA
    World Clinical Drug. 2018, 39(10): 691-694.
    Objective

    To analyze the cost-effectiveness of three therapeutic regimens in the treatment of child acute upper respiratory infection (AURI).

    Methods

    A total of 92 children with AURI admitted in our hospital from April 2015 to July 2016 were enrolled and divided to three groups. The group A (n=30) was treated with cefotiam for injection, the group B (n=34) was treated with cefaclor plus bromhexine hydrochloride suspension and the group C (n=28) was treated with Yanhuning injection combined with Qingkailing injection. The treatment was lasted about 7 days. The efficacy, adverse drug reactions and drug economic costs of the three groups were compared.

    Results

    Compared with the group B and group C, the group A had a lower number of cured cases, more invalid cases and a longer hospital stay (P<0.05), but the total effective rate of the three groups was similar. The drug cost-effectiveness ratio of group C was the highest, while that in group B was the lowest. No obvious adverse drug reactions were observed in all groups.

    Conclusion

    Compared with cefotiam and the Yanhuning injection combined with Qingkailing injection, the cefaclor plus bromhexine hydrochloride suspension has lower cost and similar efficacy in the treatment of child AURI.

  • Wen-jing YE, Feng-feng HAN, Yan-min WANG, Wen-bin GUAN, Xue-jun GUO
    World Clinical Drug. 2018, 39(10): 695-698.
  • Li-hong LYU, Zhi-ru XU
    World Clinical Drug. 2018, 39(10): 699-704.

    Calcitriol is one of the most important active metabolites of vitamin D3, which is responsible for the biological function of vitamin D3. Studies have shown that calcitriol is associated with many diseases, and its content in the human body is also affected by diseases. This review describes the function of endogenous calcitriol, and its interaction with the disease development.

  • Gang ZHENG
    World Clinical Drug. 2018, 39(10): 705-711.

    Pulmonary hypertension (PH) is a common clinical disease and can be caused by various heart and lung diseases. The PH caused by left heart disease (PH-LHD) is the most common, which can induce the dyspnea, fatigue, reduced exercise tolerance and even heart failure. However, the PH-LHD may have high rate of disability and mortality, and seriously affect patients' life quality. With extensive study of PH-LHD pathophysiological mechanism, the targeted drugs have been developed, which causes more and more attention. This review summarizes PH-LHD related targeted therapeutic drugs for clinical reference.

  • Yang XU, Kai-xiong LIU, Jie-ming QU
    World Clinical Drug. 2018, 39(10): 712-715.

    Serum immunoglobulin E (IgE) is an important marker for allergic bronchopulmonary aspergillosis (ABPA). The traditional treatment with steroids and antifungal drugs has limited efficacy and several side effects. Omalizumab, as a recombinant humanized IgE monoclonal antibody, can effectively regulate cytokines and reduce IgE expression to improve ABPA patients' symptoms with fewer side effects. This article summarizes the recent research in the treatment of ABPA with omalizumab to provide a clinical reference for ABPA treatment.

  • Fei LIU, Zheng LU
    World Clinical Drug. 2018, 39(10): 716-720.

    This article gives an interpretation for "expert consensus for the clinical use of benzodiazepines" based on relevant literature and author's clinical experience. Through the characteristics of benzodiazepines, clinical rational use, special population user and adverse drug reactions, this review provides a reference for clinical application.

  • Lan MA, Ye-sheng PAN
    World Clinical Drug. 2018, 39(9): S37-S40.

    Angiotensin receptor and neprilysin inhibitor (ARNI) is the most important discovery in the treatment of heart failure in recent years, but the use of ARNI at home and abroad is still very low. In this paper, the background, mechanism and clinical research results of ARNI are discussed.

News